Life Sciences and Healthcare

Australia’s life sciences and health sectors are evolving rapidly, driven by scientific discovery, increased investment and growing regulatory oversight. Our team works with organisations across the full ecosystem including biotechnology companies, pharmaceutical manufacturers, medical device developers, researchers, universities, health service providers and investors.

We assist our clients to navigate and manage the complex and often intersecting legal frameworks that apply to the creation, development, protection, commercialisation and delivery of scientific and medical innovation and health outcomes.

The Bartier Perry team combines deep legal capability with a practical understanding of the scientific, commercial and regulatory environment our clients operate in. We advise on matters across the entire lifecycle of a product or technology, driving progress from concept to commercial realisation. This includes early‑stage research and funding arrangements, clinical trials, market entry, compliance, commercialisation, disputes and regulatory investigations.

Clients tell us they value our pragmatic, down‑to‑earth approach and our ability to translate complex scientific and regulatory issues into clear, commercial advice. We partner with clients to identify risks early, streamline decision‑making and progress matters efficiently. Additionally, we work collaboratively with experts, regulators and industry bodies to ensure our clients receive guidance that is technically sound and aligned with their strategic goals.

Bartier Perry’s experience in this sector also draws on our strengths across corporate and commercial law, intellectual property, employment, privacy, governance, disputes and government advisory ensuring clients receive integrated advice.

 

We work with

• Biotech and pharmaceutical organisations

• Medical device and diagnostics manufacturers

• Hospitals and health service providers

• Research institutes and universities

• Start‑ups, spin‑outs and emerging enterprises

• Investors and venture capital firms

• Government and regulatory agencies

 

What we advise on

Regulatory and compliance

• The frameworks administered by the TGA, OGTR and other regulators

• Compliance programs, governance and risk management

• Advertising and marketing compliance/product defence, including therapeutic goods claims

• Product recalls, post‑market monitoring and regulatory investigations

Clinical trials and basic research

• Drafting and negotiating clinical trial agreements and related documentation

• Ethics and governance requirements

• Data, privacy and participant consent issues

• Research collaborations, joint ventures and funding arrangements

Intellectual property

• Protection and commercialisation of patents, trademarks, designs and confidential information

• Licensing and technology transfer

• IP strategy for emerging and scaling organisations

• Resolving disputes involving ownership, misuse or infringement including litigation

Commercial and corporate

• Supply, distribution, manufacturing and services agreements

• Mergers and acquisitions, investments and structuring

• Partnerships with universities, research institutes and global collaborators

• Commercial risk allocation across complex scientific and technical projects

Disputes and investigations

• Scientific fraud, clinical trial data integrity and research misconduct matters

• Contract, partnership, investor and joint venture disputes

• Regulatory and disciplinary proceedings

• Product liability and consumer law claims